Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza

NCT00192413 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3009

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Cold-adapted influenza vaccine trivalent (CAIV-T)
BIOLOGICAL: Trivalent Inactivated Vaccine (TIV)

Sponsor

MedImmune LLC

Collaborators

[object Object]